Randomized trial data indicate that heart disease risk associated with elevated hsCRP can be cut by almost half with a safe, proven pharmacologic therapy.
Paul M. Ridker, MD
Advertisement
Articles by Paul M. Ridker, MD
Advertisement
Latest Updated Articles
- Statin Therapy for Elevated hsCRP: What Are the Public Health Implications?
Published: August 11th 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
High Fiber Linked to Fewer Bowel Symptoms in CRC Survivors
3
A Prescription for Improving Biomarker Testing for More Patients
4
Risk-Based Contracts May Not Cut Low-Value Care in Medicare Advantage
5
